Methods:
The study was conducted between March 15, 2020 to April 15, 2020 during the COVID-19 pandemic in three different hospitals in Northern New Jersey, USA, which continues to be one of the COVID-19 hotspots in the United states. We included in our study patients who were COVID positive by polymerase chain reaction test (PCR) and had echocardiogram done during the same admission. Due to the high risk to the sonographers for exposure, echocardiography was performed only on patients where it was expected to alter management and to identify possible complications. All of the studies were performed in patient rooms on medical floors and intensive care units to decrease the risk of spread of infection while moving patients. The equipment was cleaned pre and post procedures as per guidelines set up by the infectious disease control of the hospital. All echocardiographic parameters were obtained as recommended by American Society of echocardiography (ASE). The echocardiographic findings were interpreted by a board certified  cardiologist. Historical and laboratory data was obtained retrospectively from electronic medical record review.